AVRA ADAIR: Open Payments
NPI 1194137653 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 6 payments from 5 companies in 2025. Trend: 2023 $219 · 2024 $216 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
Products named: FARXIGA, Fabhalta, TARPEYO, Kerendia, JARDIANCE.
Industry payments across AL — which companies pay providers there.
